Because the resource use and direct cost of glaucoma treatment and management increases as the disease severity worsens-- from an average $623 per early-stage patient to $2,511 per late-stage patient-- a glaucoma treatment that delays the disease progression could significantly reduce its economic burden.
---
Lee, Paul P., John G. Walt, John L. Doyle, Sameer V. Kotak, Stacy J. Evans, Donald L. Budenz, Philip P. Chen, Anne L. Coleman, Robert M. Feldman, Henry D. Jampel, L. Jay Katz, Richard P. Mills, Jonathan S. Myers, Robert J. Noecker, et al. "A Multicenter, Retrospective Pilot Study of Resource Use and Costs Associated with Severity of Disease in Glaucoma". Archives of Ophthalmology. Vol. 124, No. 1, pp. 12-9. [ Permalink ] |